Antithrombin (Recombinant) Market, Global Outlook and Forecast 2022-2028

February 2022 | 75 pages | ID: A8234529246BEN
Market Monitor Global

Abstracts

Recombinant antithrombins with properties similar to those of normal human antithrombin have been produced using baculovirus-infected insect cells and mammalian cell lines grown in cell culture.

This report contains market size and forecasts of Antithrombin (Recombinant) in global, including the following market information:

Global Antithrombin (Recombinant) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Antithrombin (Recombinant) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Antithrombin (Recombinant) companies in 2021 (%)

The global Antithrombin (Recombinant) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lyophilized Formulation Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antithrombin (Recombinant) include LFB Biotechnologies. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antithrombin (Recombinant) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antithrombin (Recombinant) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antithrombin (Recombinant) Market Segment Percentages, by Type, 2021 (%)

• Lyophilized Formulation
• Lyophilized Powder

Global Antithrombin (Recombinant) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antithrombin (Recombinant) Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic

Global Antithrombin (Recombinant) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antithrombin (Recombinant) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antithrombin (Recombinant) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antithrombin (Recombinant) revenues share in global market, 2021 (%)

Key companies Antithrombin (Recombinant) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Antithrombin (Recombinant) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• LFB Biotechnologies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antithrombin (Recombinant) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antithrombin (Recombinant) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTITHROMBIN (RECOMBINANT) OVERALL MARKET SIZE

2.1 Global Antithrombin (Recombinant) Market Size: 2021 VS 2028
2.2 Global Antithrombin (Recombinant) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antithrombin (Recombinant) Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Antithrombin (Recombinant) Players in Global Market
3.2 Top Global Antithrombin (Recombinant) Companies Ranked by Revenue
3.3 Global Antithrombin (Recombinant) Revenue by Companies
3.4 Global Antithrombin (Recombinant) Sales by Companies
3.5 Global Antithrombin (Recombinant) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antithrombin (Recombinant) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antithrombin (Recombinant) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antithrombin (Recombinant) Players in Global Market
  3.8.1 List of Global Tier 1 Antithrombin (Recombinant) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Antithrombin (Recombinant) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antithrombin (Recombinant) Market Size Markets, 2021 & 2028
  4.1.2 Lyophilized Formulation
  4.1.3 Lyophilized Powder
4.2 By Type - Global Antithrombin (Recombinant) Revenue & Forecasts
  4.2.1 By Type - Global Antithrombin (Recombinant) Revenue, 2017-2022
  4.2.2 By Type - Global Antithrombin (Recombinant) Revenue, 2023-2028
  4.2.3 By Type - Global Antithrombin (Recombinant) Revenue Market Share, 2017-2028
4.3 By Type - Global Antithrombin (Recombinant) Sales & Forecasts
  4.3.1 By Type - Global Antithrombin (Recombinant) Sales, 2017-2022
  4.3.2 By Type - Global Antithrombin (Recombinant) Sales, 2023-2028
  4.3.3 By Type - Global Antithrombin (Recombinant) Sales Market Share, 2017-2028
4.4 By Type - Global Antithrombin (Recombinant) Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antithrombin (Recombinant) Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
5.2 By Application - Global Antithrombin (Recombinant) Revenue & Forecasts
  5.2.1 By Application - Global Antithrombin (Recombinant) Revenue, 2017-2022
  5.2.2 By Application - Global Antithrombin (Recombinant) Revenue, 2023-2028
  5.2.3 By Application - Global Antithrombin (Recombinant) Revenue Market Share, 2017-2028
5.3 By Application - Global Antithrombin (Recombinant) Sales & Forecasts
  5.3.1 By Application - Global Antithrombin (Recombinant) Sales, 2017-2022
  5.3.2 By Application - Global Antithrombin (Recombinant) Sales, 2023-2028
  5.3.3 By Application - Global Antithrombin (Recombinant) Sales Market Share, 2017-2028
5.4 By Application - Global Antithrombin (Recombinant) Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antithrombin (Recombinant) Market Size, 2021 & 2028
6.2 By Region - Global Antithrombin (Recombinant) Revenue & Forecasts
  6.2.1 By Region - Global Antithrombin (Recombinant) Revenue, 2017-2022
  6.2.2 By Region - Global Antithrombin (Recombinant) Revenue, 2023-2028
  6.2.3 By Region - Global Antithrombin (Recombinant) Revenue Market Share, 2017-2028
6.3 By Region - Global Antithrombin (Recombinant) Sales & Forecasts
  6.3.1 By Region - Global Antithrombin (Recombinant) Sales, 2017-2022
  6.3.2 By Region - Global Antithrombin (Recombinant) Sales, 2023-2028
  6.3.3 By Region - Global Antithrombin (Recombinant) Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Antithrombin (Recombinant) Revenue, 2017-2028
  6.4.2 By Country - North America Antithrombin (Recombinant) Sales, 2017-2028
  6.4.3 US Antithrombin (Recombinant) Market Size, 2017-2028
  6.4.4 Canada Antithrombin (Recombinant) Market Size, 2017-2028
  6.4.5 Mexico Antithrombin (Recombinant) Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Antithrombin (Recombinant) Revenue, 2017-2028
  6.5.2 By Country - Europe Antithrombin (Recombinant) Sales, 2017-2028
  6.5.3 Germany Antithrombin (Recombinant) Market Size, 2017-2028
  6.5.4 France Antithrombin (Recombinant) Market Size, 2017-2028
  6.5.5 U.K. Antithrombin (Recombinant) Market Size, 2017-2028
  6.5.6 Italy Antithrombin (Recombinant) Market Size, 2017-2028
  6.5.7 Russia Antithrombin (Recombinant) Market Size, 2017-2028
  6.5.8 Nordic Countries Antithrombin (Recombinant) Market Size, 2017-2028
  6.5.9 Benelux Antithrombin (Recombinant) Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Antithrombin (Recombinant) Revenue, 2017-2028
  6.6.2 By Region - Asia Antithrombin (Recombinant) Sales, 2017-2028
  6.6.3 China Antithrombin (Recombinant) Market Size, 2017-2028
  6.6.4 Japan Antithrombin (Recombinant) Market Size, 2017-2028
  6.6.5 South Korea Antithrombin (Recombinant) Market Size, 2017-2028
  6.6.6 Southeast Asia Antithrombin (Recombinant) Market Size, 2017-2028
  6.6.7 India Antithrombin (Recombinant) Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Antithrombin (Recombinant) Revenue, 2017-2028
  6.7.2 By Country - South America Antithrombin (Recombinant) Sales, 2017-2028
  6.7.3 Brazil Antithrombin (Recombinant) Market Size, 2017-2028
  6.7.4 Argentina Antithrombin (Recombinant) Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Antithrombin (Recombinant) Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Antithrombin (Recombinant) Sales, 2017-2028
  6.8.3 Turkey Antithrombin (Recombinant) Market Size, 2017-2028
  6.8.4 Israel Antithrombin (Recombinant) Market Size, 2017-2028
  6.8.5 Saudi Arabia Antithrombin (Recombinant) Market Size, 2017-2028
  6.8.6 UAE Antithrombin (Recombinant) Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 LFB Biotechnologies
  7.1.1 LFB Biotechnologies Corporate Summary
  7.1.2 LFB Biotechnologies Business Overview
  7.1.3 LFB Biotechnologies Antithrombin (Recombinant) Major Product Offerings
  7.1.4 LFB Biotechnologies Antithrombin (Recombinant) Sales and Revenue in Global (2017-2022)
  7.1.5 LFB Biotechnologies Key News

8 GLOBAL ANTITHROMBIN (RECOMBINANT) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Antithrombin (Recombinant) Production Capacity, 2017-2028
8.2 Antithrombin (Recombinant) Production Capacity of Key Manufacturers in Global Market
8.3 Global Antithrombin (Recombinant) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTITHROMBIN (RECOMBINANT) SUPPLY CHAIN ANALYSIS

10.1 Antithrombin (Recombinant) Industry Value Chain
10.2 Antithrombin (Recombinant) Upstream Market
10.3 Antithrombin (Recombinant) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Antithrombin (Recombinant) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Antithrombin (Recombinant) in Global Market
Table 2. Top Antithrombin (Recombinant) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antithrombin (Recombinant) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antithrombin (Recombinant) Revenue Share by Companies, 2017-2022
Table 5. Global Antithrombin (Recombinant) Sales by Companies, (K Units), 2017-2022
Table 6. Global Antithrombin (Recombinant) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antithrombin (Recombinant) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Antithrombin (Recombinant) Product Type
Table 9. List of Global Tier 1 Antithrombin (Recombinant) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antithrombin (Recombinant) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antithrombin (Recombinant) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antithrombin (Recombinant) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antithrombin (Recombinant) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antithrombin (Recombinant) Sales (K Units), 2017-2022
Table 15. By Type - Global Antithrombin (Recombinant) Sales (K Units), 2023-2028
Table 16. By Application – Global Antithrombin (Recombinant) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antithrombin (Recombinant) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antithrombin (Recombinant) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antithrombin (Recombinant) Sales (K Units), 2017-2022
Table 20. By Application - Global Antithrombin (Recombinant) Sales (K Units), 2023-2028
Table 21. By Region – Global Antithrombin (Recombinant) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antithrombin (Recombinant) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antithrombin (Recombinant) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antithrombin (Recombinant) Sales (K Units), 2017-2022
Table 25. By Region - Global Antithrombin (Recombinant) Sales (K Units), 2023-2028
Table 26. By Country - North America Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antithrombin (Recombinant) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antithrombin (Recombinant) Sales, (K Units), 2017-2022
Table 29. By Country - North America Antithrombin (Recombinant) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antithrombin (Recombinant) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antithrombin (Recombinant) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antithrombin (Recombinant) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antithrombin (Recombinant) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antithrombin (Recombinant) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antithrombin (Recombinant) Sales, (K Units), 2023-2028
Table 38. By Country - South America Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antithrombin (Recombinant) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antithrombin (Recombinant) Sales, (K Units), 2017-2022
Table 41. By Country - South America Antithrombin (Recombinant) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antithrombin (Recombinant) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antithrombin (Recombinant) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antithrombin (Recombinant) Sales, (K Units), 2023-2028
Table 46. LFB Biotechnologies Corporate Summary
Table 47. LFB Biotechnologies Antithrombin (Recombinant) Product Offerings
Table 48. LFB Biotechnologies Antithrombin (Recombinant) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Antithrombin (Recombinant) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 50. Global Antithrombin (Recombinant) Capacity Market Share of Key Manufacturers, 2020-2022
Table 51. Global Antithrombin (Recombinant) Production by Region, 2017-2022 (K Units)
Table 52. Global Antithrombin (Recombinant) Production by Region, 2023-2028 (K Units)
Table 53. Antithrombin (Recombinant) Market Opportunities & Trends in Global Market
Table 54. Antithrombin (Recombinant) Market Drivers in Global Market
Table 55. Antithrombin (Recombinant) Market Restraints in Global Market
Table 56. Antithrombin (Recombinant) Raw Materials
Table 57. Antithrombin (Recombinant) Raw Materials Suppliers in Global Market
Table 58. Typical Antithrombin (Recombinant) Downstream
Table 59. Antithrombin (Recombinant) Downstream Clients in Global Market
Table 60. Antithrombin (Recombinant) Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Antithrombin (Recombinant) Segment by Type
Figure 2. Antithrombin (Recombinant) Segment by Application
Figure 3. Global Antithrombin (Recombinant) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antithrombin (Recombinant) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antithrombin (Recombinant) Revenue, 2017-2028 (US$, Mn)
Figure 7. Antithrombin (Recombinant) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antithrombin (Recombinant) Revenue in 2021
Figure 9. By Type - Global Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 10. By Type - Global Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antithrombin (Recombinant) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 13. By Application - Global Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antithrombin (Recombinant) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 16. By Region - Global Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 19. US Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 24. Germany Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 25. France Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 33. China Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 37. India Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 40. Brazil Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antithrombin (Recombinant) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antithrombin (Recombinant) Sales Market Share, 2017-2028
Figure 44. Turkey Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antithrombin (Recombinant) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antithrombin (Recombinant) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antithrombin (Recombinant) by Region, 2021 VS 2028
Figure 50. Antithrombin (Recombinant) Industry Value Chain
Figure 51. Marketing Channels